CN Patent

CN116887844A — 用于治疗骨髓增生异常综合征的他喹莫德或其药学上可接受的盐

Assigned to Active Biotech AB · Expires 2023-10-13 · 3y expired

What this patent protects

用于治疗骨髓增生异常综合征(MDS)的他喹莫德或其药学上可接受的盐。

USPTO Abstract

用于治疗骨髓增生异常综合征(MDS)的他喹莫德或其药学上可接受的盐。

Drugs covered by this patent

imetelstat-sodium (IMETELSTAT SODIUM)

Patent Metadata

Patent number: CN116887844A
Jurisdiction: CN
Classification: —
Expires: 2023-10-13
Drug substance claim: No
Drug product claim: No
Assignee: Active Biotech AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.